Yesterday, March 23, 2016, 65 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $249.20 to $12,675,000.00.

Highlighted Stocks Traded by Insiders:

NxStage Medical (NXTM) - FREE Research Report

Turk Joseph E Jr, who is President at NxStage Medical, sold 2,000 shares at $14.34 on March 23, 2016. Following this transaction, the President owned 108,280 shares meaning that the stake was reduced by 1.81% with the 2,000-share transaction.

The shares most recently traded at $14.05, down $0.29, or 2.06% since the insider transaction. Historical insider transactions for NxStage Medical go as follows:

  • 4-Week # shares bought: 1,500
  • 4-Week # shares sold: 1,500
  • 12-Week # shares bought: 22,500
  • 12-Week # shares sold: 10,380
  • 24-Week # shares bought: 22,500
  • 24-Week # shares sold: 36,113

The average volume for NxStage Medical has been 589,300 shares per day over the past 30 days. NxStage Medical has a market cap of $938.7 million and is part of the health care sector and health services industry. Shares are down 34.87% year-to-date as of the close of trading on Wednesday.

NxStage Medical, Inc., a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Currently, there are 5 analysts who rate NxStage Medical a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on NXTM - FREE

TheStreet Quant Ratings

rates NxStage Medical as a

hold

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income and revenue growth. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. Get the full

NxStage Medical Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Facebook (FB) - FREE Research Report

Stretch Colin, who is VP and General Counsel at Facebook, sold 1,000 shares at $111.34 on March 23, 2016. Following this transaction, the VP and General Counsel owned 78,753 shares meaning that the stake was reduced by 1.25% with the 1,000-share transaction.

The shares most recently traded at $112.17, up $0.83, or 0.74% since the insider transaction. Historical insider transactions for Facebook go as follows:

  • 4-Week # shares sold: 147,392
  • 12-Week # shares sold: 251,682
  • 24-Week # shares sold: 358,960

The average volume for Facebook has been 35.7 million shares per day over the past 30 days. Facebook has a market cap of $319.5 billion and is part of the technology sector and internet industry. Shares are up 7.54% year-to-date as of the close of trading on Wednesday.

Facebook, Inc. operates as a mobile application and Website that enables people to connect, share, discover, and communicate each other on mobile devices and personal computers worldwide. The company has a P/E ratio of 86.1. Currently, there are 27 analysts who rate Facebook a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on FB - FREE

TheStreet Quant Ratings

rates Facebook as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

Facebook Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Era Group (ERA) - FREE Research Report

Shah Shefali A, who is SVP, Gen. Counsel & Corp. Sec. at Era Group, sold 5,114 shares at $10.24 on March 23, 2016. Following this transaction, the SVP, Gen. Counsel & Corp. Sec. owned 79,790 shares meaning that the stake was reduced by 6.02% with the 5,114-share transaction.

Bradshaw Christopher Scott, who is Director, CEO at Era Group, sold 14,945 shares at $10.76 on March 23, 2016. Following this transaction, the Director, CEO owned 197,151 shares meaning that the stake was reduced by 7.05% with the 14,945-share transaction.

White Paul T, who is SVP - Commercial at Era Group, sold 2,687 shares at $10.24 on March 23, 2016. Following this transaction, the SVP - Commercial owned 55,909 shares meaning that the stake was reduced by 4.59% with the 2,687-share transaction.

Whalen Jennifer Dawn, who is Chief Accounting Officer at Era Group, sold 985 shares at $10.24 on March 23, 2016. Following this transaction, the Chief Accounting Officer owned 25,107 shares meaning that the stake was reduced by 3.78% with the 985-share transaction.

The shares most recently traded at $8.83, down $1.41, or 15.96% since the insider transaction. Historical insider transactions for Era Group go as follows:

  • 4-Week # shares bought: 13,929
  • 4-Week # shares sold: 7,622
  • 12-Week # shares bought: 13,929
  • 12-Week # shares sold: 7,622
  • 24-Week # shares bought: 13,929
  • 24-Week # shares sold: 7,622

The average volume for Era Group has been 145,700 shares per day over the past 30 days. Era Group has a market cap of $197.6 million and is part of the services sector and transportation industry. Shares are down 19.28% year-to-date as of the close of trading on Wednesday.

Era Group Inc. provides helicopter transportation services primarily to the oil and gas exploration, development, and production companies. The company has a P/E ratio of 24.9. Currently, there is 1 analyst who rates Era Group a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ERA - FREE

TheStreet Quant Ratings

rates Era Group as a

hold

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, disappointing return on equity and a generally disappointing performance in the stock itself. Get the full

Era Group Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.